CFM
HURA

Catalyst Funds Management’s TuHURA Biosciences HURA Stock Holding History

Catalyst Funds Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
+47,201
New +$110K 0.01% 612

Other funds holding HURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $481M AUM 20.5% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $798M AUM 14.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Catalyst Funds Management's HURA Position: Q2 2026 in Review

Catalyst Funds Management opened a new position in TuHURA Biosciences (HURA) in Q2 2026: 47,201 shares worth $110K. The stake represents 0.01% of the portfolio and ranks #612 among its holdings.

37 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Catalyst Funds Management held 47,201 shares of TuHURA Biosciences worth $110K as of Q2 2026.
  • TuHURA Biosciences was a new Catalyst Funds Management position in Q2 2026.
  • TuHURA Biosciences made up 0.01% of Catalyst Funds Management's portfolio in Q2 2026, its #612 holding.
  • 37 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.